The Neurobiochemistry Laboratory at the Neurosciences Centre (NSC) of All India Institute of Medical Sciences (AIIMS), Delhi, has launched an advanced Therapeutic Drug Monitoring (TDM) facility for epilepsy patients, the hospital said on Sunday.
The facility is aimed at strengthening epilepsy care and improving access to affordable, high-quality neurodiagnostic services for patients across the country. TDM is an area of clinical chemistry that specialises in measuring medication level concentrations in patients and is said to improve epilepsy care.
The facility has been established to support clinicians in optimising antiepileptic therapy through accurate monitoring of therapeutic drug levels, individualised dose adjustment, assessment of treatment response, and early detection of drug toxicity.
“The availability of these tests within AIIMS is expected to provide major relief to economically underprivileged patients who previously had to rely on expensive private laboratories or external referral centres for such specialised investigations,” AIIMS said in a statement.